Form 8-K - Current report:
SEC Accession No. 0001193125-25-162644
Filing Date
2025-07-22
Accepted
2025-07-22 17:01:16
Documents
17
Period of Report
2025-07-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d24616d8k.htm   iXBRL 8-K 38590
2 EX-10.1 d24616dex101.htm EX-10.1 69500
3 EX-99.1 d24616dex991.htm EX-99.1 8824
4 EX-99.2 d24616dex992.htm EX-99.2 8311
8 GRAPHIC g24616g0722072248319.jpg GRAPHIC 4293
9 GRAPHIC g24616g0722073319905.jpg GRAPHIC 4293
  Complete submission text file 0001193125-25-162644.txt   289651

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vor-20250716.xsd EX-101.SCH 2851
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20250716_lab.xml EX-101.LAB 18738
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20250716_pre.xml EX-101.PRE 11709
19 EXTRACTED XBRL INSTANCE DOCUMENT d24616d8k_htm.xml XML 3767
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 251140890
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)